A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo In Patients With Overactive Bladder.
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo In Patients With Overactive Bladder.
To evaluate the efficacy and safety of fesoterodine in comparison to placebo for overactive bladder.
Inclusion Criteria:
Exclusion Criteria:
Eiheiji-cyo,yoshida-gun,, Fukui, Japan
Koga-shi, Fukuoka, Japan
Minami-ku, Fukuoka-shi, Fukuoka, Japan
Sawara-ku, Fukuoka, Japan
Amagasaki-shi, Hyōgo, Japan
Higashinada, Hyōgo, Japan
Takaraduka-city, Hyōgo, Japan
Aira-gun, Aira-chou,, Kagoshima-ken, Japan
Kawasakishi, Kanagawa, Japan
Sagamihara-shi, Kanagawa, Japan
Tama-ku, Kawasaki-shi, Kanagawa, Japan
Tamana-shi, Kumamoto, Japan
Matsumoto-shi, Nagano, Japan
Matumoto-Shi, Nagano, Japan
Hunaki-cho, Ibaraki-shi, Osaka, Japan
Minami-ku, Sakai-shi, Osaka, Japan
Nishinari-ku, Osaka, Japan
Suita-shi,, Osaka, Japan
Suita-shi, Osaka, Japan
Yodogawa-Ku, Osaka, Japan
Saitama-shi, Saitama, Japan
Satte-shi, Saitama, Japan
Wakou-shi, Saitama, Japan
Gotenbashi, Shizuoka, Japan
Bunkyo-ku, Tokyo, Japan
Chofu-shi, Tokyo, Japan
Chuo-ku, Tokyo, Japan
Fucyushi, Tokyo, Japan
Koto-ku, Tokyo, Japan
Nakano-ku, Tokyo, Japan
Setagaya-ku, Tokyo, Japan
Setgaya-ku, Tokyo, Japan
Shibuya-ku, Tokyo, Japan
Shinjuku-ku, Tokyo, Japan
Suginami-ku, Tokyo, Japan
Sumida-ku, Tokyo, Japan
Chuou-shi, Yamanashi, Japan
Cheonan-si, Chungcheongnam-do 330-715, South Korea
Chiayi Country, 613, Taiwan
Koahsiung, 833, Taiwan